ClinicalTrials.gg
CompletedNCT00198523Updated Mar 15, 2013

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

A Phase 3 interventional study of Prednisolone and Tobramycin and Prednisolone in Eye Infections and Postoperative Complications, sponsored by Bausch & Lomb Incorporated. Completed at 6 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-03-15.

Sponsored by Bausch & Lomb Incorporated (part of Bausch Health Companies Inc.) · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 10 studies in Eye Infections with a site in United States — 1 open to participants now, 1 under way, 1 of them phase 3. Eye Infections · United States.

Started
2005
the only one that year
Phase 3
5 of 10
1 open now
Registered
3rd of 10
by date
Lead sponsor
1 of 10
Bausch & Lomb Incorporated

Among the 10 studies in Eye Infections with a site in United States, this one is the only one that started in 2005, is one of 5 in phase 3, and was the 3rd registered.

Eye Infections

31 studies on the registry are indexed under Eye Infections; 4 are open to participants now.

Browse Eye Infections studies →

Open to participants now

1 of the 10 studies in Eye Infections with a site in United States is open now. Recruiting first, the newest first:

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 3 Eye Infections studies recruiting now, 3 set no upper age limit and none stop at 75 or younger; 3 take children under 18; none take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Eye Infections with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to demonstrate the bioequivalence of the combination test agent, prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension compared to PredForte (prednisolone acetate 1.0%) ophthalmic suspension. Bioequivalence will be measured by comparing aqueous humor concentrations of prednisolone acetate.

03

Conditions studied

  • Eye Infections
  • Postoperative Complications

Keywords

  • Cataract Extraction
  • Anti-Bacterial Agents
  • Steroids
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Bilateral cataract surgery
  • Avoid disallowed medications throughout study

Exclusion criteria

Exclusion Criteria:

  • to the use of the test agents
  • Known allergy or sensitivity to the test agents or components
  • History of response following topical administration of corticosteroids in the eye
  • Wore contact lenses 48 hours prior to Visit 1
  • An intraocular pressure that is greater than 22 mmHg or less than 5 mmHg in either eye
  • Any significant illness that could be expected to interfere with study
  • Used ophthalmic, topical or systemic corticosteroids or an immunomodulator for 7 days prior to surgery
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
132 participants

Study arms

  • Experimental
    Prednisolone and Tobramycin

    Prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension. One drop of test agent will be instilled in the inferior cul de sac of the operative eye prior to cataract extraction.

    Drug: Prednisolone and Tobramycin

  • Active comparator
    Prednisolone

    Prednisolone acetate 1.0% ophthalmic suspension. One drop of test agent will be instilled in the inferior cul de sac of the operative eye prior to cataract extraction.

    Drug: Prednisolone

Interventions

06

What researchers measure

Primary outcomes

  1. Bioequivalence will be measured by comparing aqueous humor concentrations of prednisolone acetate at various time points

    Comparison of aqueous humor concentrations of prednisolone acetate at various time points

    Time frame: 2 days

07

Study locations

6 sites
  • Donald E. Beahm, MD
    Great Bend, Kansas 67530, United States
  • Cornea Consultants/Laser Eye Consultants of Boston
    Boston, Massachusetts 02114, United States
  • Great Lakes Eye Care
    St. Joseph, Michigan 49085, United States
  • Eyesight Ophthalmic Services, PA
    Portsmouth, New Hampshire 03801, United States
  • Texan Eye Care PA
    Austin, Texas 78705, United States
  • Houston Eye Associates
    Houston, Texas 77025, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2005, a primary completion of Oct 2005 and a completion of Oct 2005. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2005
First posted
Sep 20, 2005
Start
Jul 2005
Primary completionActual
Oct 2005
CompletionActual
Oct 2005
Last update
Mar 15, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 15, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00198523
Responsible party
Sponsor
First posted
Sep 20, 2005
Start date
Jul 2005
Primary completion
Oct 2005
Completion
Oct 2005
Last update
Mar 15, 2013

Study contacts

Tim McNamara, PharmD
study director · ISTA Pharmaceuticals, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Prednisolone · Tobramycin

Start the discussion